OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey
Francesco Fiorentino, Martina Menna, Dante Rotili, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1654-1677
Open Access | Times Cited: 54
Francesco Fiorentino, Martina Menna, Dante Rotili, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1654-1677
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 68
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 68
Discovery of a PROTAC degrader for METTL3-METTL14 complex
Wenhao Du, Yuting Huang, Xiaoai Chen, et al.
Cell chemical biology (2024) Vol. 31, Iss. 1, pp. 177-183.e17
Closed Access | Times Cited: 25
Wenhao Du, Yuting Huang, Xiaoai Chen, et al.
Cell chemical biology (2024) Vol. 31, Iss. 1, pp. 177-183.e17
Closed Access | Times Cited: 25
A Stapled Peptide Inhibitor Targeting the Binding Interface of N6‐Adenosine‐Methyltransferase Subunits METTL3 and METTL14 for Cancer Therapy
Zenghui Li, Yuqing Feng, Hong Han, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 24
Closed Access | Times Cited: 17
Zenghui Li, Yuqing Feng, Hong Han, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 24
Closed Access | Times Cited: 17
Aberrant splicing in Huntington’s disease accompanies disrupted TDP-43 activity and altered m6A RNA modification
Thai B. Nguyen, Ricardo Miramontes, Carlos Chillón-Marinas, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 2
Thai B. Nguyen, Ricardo Miramontes, Carlos Chillón-Marinas, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 2
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 2
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 2
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models
Guillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 2
Guillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 2
Advances in targeting RNA modifications for anticancer therapy
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 30
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 30
Chemical Inhibitors Targeting the Oncogenic m6A Modifying Proteins
Yue Huang, Wenyang Xia, Ze Dong, et al.
Accounts of Chemical Research (2023) Vol. 56, Iss. 21, pp. 3010-3022
Closed Access | Times Cited: 30
Yue Huang, Wenyang Xia, Ze Dong, et al.
Accounts of Chemical Research (2023) Vol. 56, Iss. 21, pp. 3010-3022
Closed Access | Times Cited: 30
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation
Monica Pomaville, Mohansrinivas Chennakesavalu, Pingluan Wang, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114165-114165
Open Access | Times Cited: 13
Monica Pomaville, Mohansrinivas Chennakesavalu, Pingluan Wang, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114165-114165
Open Access | Times Cited: 13
A novel pyridine-2-one AMPK inhibitor: discovery, mechanism, and in vivo evaluation in a hypoxic pulmonary arterial hypertension rat model
Wenhua Tan, Yu Wang, Mengqi Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117266-117266
Closed Access | Times Cited: 1
Wenhua Tan, Yu Wang, Mengqi Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117266-117266
Closed Access | Times Cited: 1
Structure-Based Design of Inhibitors of the m6A-RNA Writer Enzyme METTL3
R.K. Bedi, Danzhi Huang, Yaozong Li, et al.
ACS Bio & Med Chem Au (2023) Vol. 3, Iss. 4, pp. 359-370
Open Access | Times Cited: 19
R.K. Bedi, Danzhi Huang, Yaozong Li, et al.
ACS Bio & Med Chem Au (2023) Vol. 3, Iss. 4, pp. 359-370
Open Access | Times Cited: 19
Aberrant splicing in Huntington’s disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification
Thai B. Nguyen, Ricardo Miramontes, Carlos Chillón-Marinas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
Thai B. Nguyen, Ricardo Miramontes, Carlos Chillón-Marinas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
A Stapled Peptide Inhibitor Targeting the Binding Interface of N6‐Adenosine‐Methyltransferase Subunits METTL3 and METTL14 for Cancer Therapy
Zenghui Li, Yuqing Feng, Hong Han, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 24
Closed Access | Times Cited: 5
Zenghui Li, Yuqing Feng, Hong Han, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 24
Closed Access | Times Cited: 5
RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 5
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 5
Regulations of m6A and other RNA modifications and their roles in cancer
Xinhui Chen, Kunxiong Guo, Jing Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 622-648
Closed Access | Times Cited: 5
Xinhui Chen, Kunxiong Guo, Jing Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 622-648
Closed Access | Times Cited: 5
Enzymatically Mediated In Situ Generation of Z-Scheme Bi2S3/Bi2MoO6 Heterojunction-Based Organic Photoelectrochemical Transistor for METTL3/METTL14 Detection
Miao Zhang, Haowei Zhang, Yunlei Zhou, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 32, pp. 13086-13095
Closed Access | Times Cited: 5
Miao Zhang, Haowei Zhang, Yunlei Zhou, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 32, pp. 13086-13095
Closed Access | Times Cited: 5
METTL protein family: focusing on the occurrence, progression and treatment of cancer
Huhu Zhang, Fulin Sun, Shuyao Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Huhu Zhang, Fulin Sun, Shuyao Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Synthesis of RNA conjugates as bisubstrates for the study of transferases
Laura Iannazzo, Emmanuelle Braud, Matthieu Fonvielle, et al.
Comptes Rendus Chimie (2025) Vol. 28, Iss. G1, pp. 111-129
Open Access
Laura Iannazzo, Emmanuelle Braud, Matthieu Fonvielle, et al.
Comptes Rendus Chimie (2025) Vol. 28, Iss. G1, pp. 111-129
Open Access
Unlocking the Mysteries of Breast Cancer
Zaheer Qureshi, Faryal Altaf, Abdur Jamil, et al.
American Journal of Clinical Oncology (2025)
Closed Access
Zaheer Qureshi, Faryal Altaf, Abdur Jamil, et al.
American Journal of Clinical Oncology (2025)
Closed Access
Rethinking RNA Modifications: Therapeutic Strategies for Targeting Dysregulated RNA
Isobel E. Bowles, Esteban A. Orellana
Journal of Molecular Biology (2025), pp. 169046-169046
Closed Access
Isobel E. Bowles, Esteban A. Orellana
Journal of Molecular Biology (2025), pp. 169046-169046
Closed Access
METTL3-mediated N6-methyladenosine modification contributes to vascular calcification
Long Li, Qing Chai, Chunling Guo, et al.
Journal of Molecular and Cellular Cardiology (2025)
Open Access
Long Li, Qing Chai, Chunling Guo, et al.
Journal of Molecular and Cellular Cardiology (2025)
Open Access
The emerging significance of the METTL family as m6A-modified RNA methyltransferases in head and neck cancer
Ming Yang, Zile Zhang, Hao Qin, et al.
Cellular Signalling (2025), pp. 111798-111798
Closed Access
Ming Yang, Zile Zhang, Hao Qin, et al.
Cellular Signalling (2025), pp. 111798-111798
Closed Access
Small molecule inhibition of RNA binding proteins in haematologic cancer
Amit Jaiswal, Michelle L. Thaxton, Georgia Scherer, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-14
Open Access | Times Cited: 3
Amit Jaiswal, Michelle L. Thaxton, Georgia Scherer, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-14
Open Access | Times Cited: 3
Liquid–liquid phase separation in diseases
Xinyue Zhang, Yuan Lin, Wanlu Zhang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
Xinyue Zhang, Yuan Lin, Wanlu Zhang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
Understanding how methyltransferase-like 3 functions in lung diseases: From pathogenesis to clinical application
Deshuang Zhang, Zhixian Gou, Yi Qu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117421-117421
Open Access | Times Cited: 3
Deshuang Zhang, Zhixian Gou, Yi Qu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117421-117421
Open Access | Times Cited: 3
